Grech-Bélanger O, Langlois S, LeBoeuf E
School of Pharmacy, Laval University, Ste-Foy, Quebec, Canada.
J Clin Pharmacol. 1988 May;28(5):477-80. doi: 10.1002/j.1552-4604.1988.tb05763.x.
The disposition of a single oral dose of diltiazem hydrochloride was studied in six male patients treated by continuous ambulatory peritoneal dialysis. Peak concentrations were obtained 2 to 4 hours postdose. The mean absorption rate constant was 0.94 +/- 0.21 (sd) hr-1, and the mean elimination half-life was 3.09 +/- 1.16 hr. Serum levels of deacetyldiltiazem, a metabolite of diltiazem, were always below 10 ng/mL. The amounts of diltiazem and deacetyldiltiazem eliminated in dialysate over 24 hours represent less than 0.1% of the administered dose. The pharmacokinetic parameters of diltiazem determined in these patients did not differ from those determined in healthy volunteers and in patients suffering from end-stage renal disease.
在6例接受持续性非卧床腹膜透析治疗的男性患者中研究了单次口服盐酸地尔硫䓬的处置情况。给药后2至4小时达到峰值浓度。平均吸收速率常数为0.94±0.21(标准差)hr⁻¹,平均消除半衰期为3.09±1.16小时。地尔硫䓬的代谢产物去乙酰地尔硫䓬的血清水平始终低于10 ng/mL。24小时内透析液中消除的地尔硫䓬和去乙酰地尔硫䓬的量占给药剂量的不到0.1%。在这些患者中测定的地尔硫䓬的药代动力学参数与在健康志愿者和终末期肾病患者中测定的参数没有差异。